Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Monsanto Licensing MIT/Harvard Genome Editing

Monsanto Company is licensing genomic editing technology for agricultural applications from a joint research center at Harvard University and MIT. . . . → Read More: Monsanto Licensing MIT/Harvard Genome Editing

Malnutrition Shown Adding Billions to U.S. Health Costs

An analysis of data from health surveys shows malnutrition associated with 8 common chronic diseases adds $15.5 billion directly to U.S. health care costs. . . . → Read More: Malnutrition Shown Adding Billions to U.S. Health Costs

Antibiotic Shown to Control Drug-Resistant Gonorrhea

Findings from a clinical trial show a candidate drug kills bacteria causing a type of gonorrhea becoming resistant to current antibiotics. . . . → Read More: Antibiotic Shown to Control Drug-Resistant Gonorrhea

Genentech, BioNTech Partner on Personal Cancer Therapies

Biotechnology company BioNTech AG is licensing its messenger RNA technology and collaborating with biopharmaceutical company Genentech to develop personalized cancer immunotherapies. . . . → Read More: Genentech, BioNTech Partner on Personal Cancer Therapies

Health Agency Funds Drug-Resistant Bacteria R&D

Biomedical Advanced Research and Development Authority, or BARDA, signed agreements worth $67 million to develop new treatments and diagnostics for urgent drug-resistant infections. . . . → Read More: Health Agency Funds Drug-Resistant Bacteria R&D

Clinical Trial Testing Live Bacteria as Acne Treatment

A clinical trial is recruiting participants to test a product with live skin bacteria made by biotechnology company AOBiome as a treatment for adult acne. . . . → Read More: Clinical Trial Testing Live Bacteria as Acne Treatment

Teva Licenses Pain Relief Antibody for $1.25 Billion

Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals. . . . → Read More: Teva Licenses Pain Relief Antibody for $1.25 Billion

FDA Holding Opioid Overdose App Competition

The U.S. Food and Drug Administration is seeking a smartphone app that can quickly find a source of the antidote drug naloxone for someone having an opioid overdose. . . . → Read More: FDA Holding Opioid Overdose App Competition

Drug Shown to Improve Cell Energy, Muscle Function

Results of a clinical trial show an experimental drug by Stealth BioTherapeutics boosts cellular energy and improves skeletal muscle functions of older adults. . . . → Read More: Drug Shown to Improve Cell Energy, Muscle Function

St. Jude, Sanger Institute to Share Genomic Databases

Two research institutes — St. Jude Children’s Research Hospital and Wellcome Trust Sanger Institute — will share their databases on cancer genomics with the other institution’s scientists. . . . → Read More: St. Jude, Sanger Institute to Share Genomic Databases